The Food and Drug Administration has issued a warning letter to GlaxoSmithKline saying letters the pharmaceutical company sent to health-care practitioners promoting cancer treatment drug Tykerb "omit and minimize the most serious and important risk information." (GSK)
Read More...
[Source: Yahoo! News Search Results for liver disease help]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment